OrthoPediatrics(KIDS) - 2025 Q4 - Annual Results

Financial Performance - OrthoPediatrics Corp. announced preliminary unaudited net revenue for Q4 2025 and full year 2025, with specific figures to be confirmed post-audit[4] - The company provided management's projection for 2026 net revenue, indicating potential growth opportunities[4] - Free cash flow estimates for Q4 2025 and full year 2025 were also disclosed, subject to final audit results[6] - The company cautioned that actual results may differ materially from preliminary estimates due to various risks and uncertainties[6] - The financial information provided is preliminary and should not be relied upon without considering the associated risks[6] Compliance and Reporting - The press release is part of the company's ongoing compliance with SEC regulations, ensuring transparency in financial reporting[5] - The company has no obligation to publicly release updates on forward-looking statements unless required by law[6] Company Information - OrthoPediatrics Corp. is listed on the Nasdaq Global Market under the trading symbol "KIDS"[2] - The company is classified as an emerging growth company, which may affect its financial reporting standards[3] - The report was signed by Daniel J. Gerritzen, General Counsel and Secretary, on January 12, 2026[10]